Background. Pulmonary involvement in leptospirosis remains poorly recognized in regions where it is endemic, despite reports of recent outbreaks and epidemic disease.
Over the past decade, pulmonary hemorrhage has been increasingly recognized throughout the world as a grave manifestation of leptospirosis [1] [2] [3] [4] [5] [6] [7] [8] . Physicians in regions where the disease is endemic often fail to recognize the association of pulmonary involvement with leptospirosis. Available diagnostic methods, such as microscopic agglutination testing (MAT) and culture, are insufficiently sensitive, specific, or timely to be of much practical use. Clinicians typically consider leptospirosis in the differential diagnosis of an acute undifferentiated fever, but only when patients present with classic textbook manifestations, such as the triad of fever, jaundice, and renal failure known as Weil disease. Moreover, when patients present with less common forms of leptospirosis [9] , as occurred in the epidemic of leptospirosis resulting in pulmonary hemorrhage that occurred in Nicaragua in 1995, the diagnosis is frequently either not considered or only discovered at autopsy [10] .
This report demonstrates the underdiagnosis of leptospirosis and the underrecognition of severe pulmonary involvement with this disease in a region of high endemicity. Pulmonary leptospirosis was present in subjects living in urban, not rural, areas. A quantitative real-time PCR assay provided rapid diagnosis of leptospirosis in severe cases. These cases of pulmonary involvement in leptospirosis, the first to be reported from Peru, again point out the high importance of this syndrome for public health. Appropriate surveillance and control measures need to be established in this and similar regions.
METHODS
Study sites. The city of Iquitos, which has a population of ∼400,000 and a surrounding rural population of ∼474,000, is a major tourist and shipping center situated 120 m above sea level (73ЊW, 3ЊS) at the juncture of the Ucayali and Marañon rivers, which forms the Amazon River proper. The urban arm of the study was conducted in the Hospital de Apoyo Iquitos, a 200-bed regional Peruvian Ministry of Health hospital serving the main city of Iquitos, with an outpatient fever clinic that operates in the context of the local malaria control program. We also studied patients in 3 neighboring rural villages, including Zungarococha (8 km from the city), Varillal (14 km), and Moralillo (16 km). All 3 villages were accessible via the paved Iquitos-Nauta road [11] .
Enrollment criteria. Outpatients who were у6 years of age with a р2-week history of fever were enrolled at the outpatient fever clinic at the Hospital de Apoyo Iquitos. Patients were excluded if results from malaria blood-smear results were positive. A systematic, prospective effort by the study team evaluated all inpatients at the Hospital de Apoyo Iquitos for those with fever and jaundice and requested permission from admitting physicians before such patients were enrolled in the study.
Case definition. All patients had laboratory evidence of recent leptospiral exposure, which was detected using a combination of culture of blood and urine specimens, serologic testing with IgM ELISA, MAT, and/or molecular evidence of the presence of leptospiral DNA in clinical specimens (see below). MAT evidence for seropositivity was defined as у1 of the following: seroconversion from negative to positive; 4-fold rise in titer between acute-phase and convalescent-phase samples; or a single titer of у800 [12] .
Protection of human subjects. This study was approved by the Ethical Committees of the Universidad Peruana Cayetano Heredia and the Asociació n Benéfica PRISMA, Lima; the Hospital de Apoyo Iquitos, Iquitos; and the Directorate of Health (DISA), Loreto, Peru; and the Institutional Review Board of the University of California San Diego, La Jolla. All patients were clinically managed by local Peruvian physicians according to regional standards. As soon as patients were identified by the study team as having possible severe leptospirosis, treating physicians were advised to administer appropriate antibiotics (parenteral ceftriaxone or penicillin) and supportive treatment.
Serologic testing. Venous blood samples were drawn into vacutainer tubes (Becton-Dickinson) without anticoagulant and transported to the study laboratory within 4 h at ambient temperature. Serum was separated, frozen in 1 mL aliquots at Ϫ20ЊC, and transported on dry ice to the National Leptospirosis Reference Laboratory at the Instituto Nacional de Salud in Lima, where the presence of antileptospiral antibodies was determined. An ELISA incorporating 6 pathogenic serovars (strains)-Icterohaemorrhagiae (RGA), Australis (Ballico), Bratislava (Jez Bratislava), Ballum (MUS127), Canicola (Hond Utretch IV), Cynopteri (3522 C), and Grippotyphosa (Moskva V)-was used to detect antileptospiral IgM antibodies [13] . MAT was performed using 26 leptospiral antigens, using the Centers for Disease Control and Prevention panel [14] plus Leptospira biflexa serovar Patoc (Patoc I) and a newly identified, antigenically distinct strain of Leptospira obtained from a febrile subject in Iquitos (provisionally designated Leptospira sp. strain Var10, with further taxonomic classification pending). MAT titers are reported as the reciprocal of the number of dilutions still agglutinating 50% of live bacterial antigen.
Leptospira culture of clinical specimens. Blood from each patient was inoculated at the bedside into semisolid PLM-5 media (Serologicals Corporation) supplemented with 200 mg/ mL of 5-fluorouracil and 2 mg/mL neomycin. Urine samples were adjusted to pH 7.0 with 1% sodium hydroxide at the time of collection, then inoculated into culture media. Cultures were transported to the study laboratory at ambient temperature within 4 h after being initiated, incubated at 28ЊC-30ЊC, examined weekly by dark-field microscopy, and discarded at 12 weeks if results were negative. Isolates were identified using MAT for serogrouping; identification at the serovar level was not performed. Commercially available rabbit polyclonal antisera (National Veterinary Services Laboratory) were used to serotype isolates. PFGE and 16S ribosomal gene sequencing were performed according to standard procedures [15, 16] ; the Basic Local Alignment Search Tool and Clustal W analysis version 1.4 (DNASTAR) were used to determine relationships between 16S gene sequences in leptospiral isolates, to reference Leptospira species sequences in GenBank, and to construct phylogenetic trees for identification purposes. Serotyping was performed at University of California San Diego; 16S gene sequencing and PFGE analysis were also done at University of California San Diego in collaboration and consultation with the Leptospirosis Reference Laboratory at the Centers for Disease Control and Prevention in Atlanta. PFGE profiles were obtained for the leptospiral serovars used in the MAT panel and for other leptospiral isolates (serogroup Icterohaemorrhagiae, Grippotyphosa, Canicola, Var10) from the Iquitos region as a reference database, against which we compared the PFGE patterns of the isolates obtained in this study. The Phoretix 1D suite of software (Nonlinear Dynamics) was used to analyze and quantitatively compare the PFGE patterns and to create phylogenetic trees for classification.
Molecular diagnosis of leptospirosis. Real-time PCR assay was performed to confirm the diagnosis of leptospirosis only for patients with pulmonary manifestations. DNA was extracted from either 200 mL of serum, sediment of urine centrifuged at 10,000 g, or 25 mg of tissue obtained at necropsy, using, in all cases, the Qiagen Tissue DNA extraction kit (Qiagen). The realtime PCR assay is based on TaqMan chemistry that specifically detects pathogenic Leptospira 16S ribosomal genes by means of a published method [17] ; the only modification in the assay is the use of the fluorescent probe at a final concentration of 2 mm. A DNA Engine Opticon 2 thermocycler (MJ Research) was used for the assays performed on site in our field laboratory in Iquitos. Standard curves for quantification were performed using Leptospira interrogans serovar Icterohaemorrhagiae and enumerated using a Petroff-Hausser counting chamber on a dark-field microscope. Wells with no template were included in each assay to detect the presence of contaminating DNA. Statistical analysis. We used a 2-sample test of proportions with a 95% confidence level. One-sided and 2-sided alternative hypotheses were tested against the null (the 2 proportions are similar). We used the statistical software STATA, version 8.0 (STATA). (table 1) . Rates of leptospiral exposure, as defined by serologic testing (IgM ELISA or MAT), were similar in both the hospital and community populations (table 1) . Rates of follow-up were greater in the rural areas, primarily because these patients were more likely to be permanent residents of the catchment area, while patients at hospitals in urban areas often come from distant places and follow-up was difficult (table 1) .
RESULTS

In
In the rural community, no cases of severe pulmonary leptospirosis occurred among the 244 patients enrolled (table 1) . Among the hospital-based patient population, 7 (3.7%) patients with serologic evidence of exposure to Leptospira had severe pulmonary forms of disease: 6 patients had hemoptysis; 1 had acute respiratory distress syndrome without hemoptysis (table  2) . No cases of typical Weil disease (i.e, jaundice or renal failure) were observed. The severity of disease differed significantly between urban and rural subjects (table 1) . Five patients died, of whom 4 had hemoptysis and 1 had ARDS and experienced multiorgan failure. One outpatient (patient 5) with hemoptysis remained ambulatory and was treated presumptively for pulmonary tuberculosis without evident effect, and resolution of disease occurred simultaneously with self-administration of amoxicillin. One hospitalized patient (patient 6) survived after several days of hemoptysis. A partial autopsy of one patient (patient 4) who had hemoptysis and died of respiratory failure (figure 1, top) had complete hemorrhagic involvement of the right lower lung ( figure 1, bottom) ; other abdominal organs appeared grossly normal. There was no other evidence of visceral hemorrhage, but mucosal bleeding was observed in the lips and gums.
The diagnosis of leptospirosis was confirmed for all patients with severe cases by a combination of serologic testing, culture, overwhelming sepsis and hemoptysis (patient 7) had negative blood and urine culture results, but real-time PCR had revealed pathogenic Leptospira in the urine. Three patients had у10 4 leptospires/mL of serum and 1 patient had 10 7 leptospires/mL of serum. One patient (patient 4) who had tissue specimens analyzed by real-time PCR had у10 5 leptospires per g of tissue. One patient with pulmonary hemorrhage who survived (patient 5) continued to have leptospiruria for 1140 days.
DISCUSSION
In this report, we describe 7 patients with leptospirosis pulmonary involvement in a region of hyperendemicity. A realtime PCR assay was useful in the rapid diagnosis of these cases. The cases of leptospirosis exhibited by these patients, particularly those with fever and hemoptysis as cardinal manifestations, were unexpected by local physicians and health authorities and would have gone undiagnosed without special efforts to find such disease. These findings not only have importance for public health in a tropical region of Peru, but they have widespread applicability.
We found severe pulmonary involvement in leptospirosis only in patients in urban settings. All of these patients lived in and, most probably, according to clinical history, were infected in the city of Iquitos. No cases were found in rural villages around Iquitos, despite evidence that the proportion of patients who had acute febrile illness with IgM antibodies or a high titer of antileptospiral antibodies by MAT was not significantly different in these 2 contrasting regions (table 1) . However, no cases of typical Weil disease were found. The reasons for the relation of severe pulmonary leptospirosis to urban acquisition of the disease are unclear. Potential explanations could include ascertainment bias (i.e, sicker patients may go to a hospital rather than an outpatient clinic), different frequencies of exposure to pathogenic leptospires in urban and rural populations [18] , differing pathogenicity of serovars present in urban and in rural environments, the focal emergence of pulmonary tropism, or varying levels of infecting Leptospira in environmental water sources of infection (i.e., inoculum effect). In this study, leptospiral seropositivity was apparently not associated with seasonal changes in water levels or the amount of rain. In contrast, in other regions, such as Nicaragua, Brazil, and India, leptospirosis and severe associated disease has been described as epidemic and associated with seasonal flooding or severe weather [4, 6, [19] [20] [21] , although pulmonary hemorrhagic manifestations were not limited to the urban setting, as was observed, for example, in Nicaragua and La Reunion.
In this study, 5 patients died; 4 deaths were associated with frank pulmonary hemorrhage. Two patients survived without apparent sequelae. In only 1 case did leptospirosis enter the differential diagnosis at the time of illness. In other cases, diagnosis was suspected only by physicians involved in the study. In all 7 patients, a real-time PCR assay provided a potentially immediate, definitive diagnosis of leptospirosis. Despite its cost, this assay has advantages over routine PCR and other PCR-based assays, such as the quantitative microplate test for clinical use, as described by Truccolo et al. [22] . The assay used here was rapid, sensitive, and specific, and was performed in closed tubes or microplates, thus minimizing cross-contamination from PCR amplicons. Quantification of Leptospira in clinical samples was also easily performed and potentially could have prognostic value. Postmortem tissue specimens from a patient who died of leptospiral pulmonary hemorrhage had high levels of leptospires in lung, liver, muscle, and kidney tissues. This is the first such quantification, to our knowledge, of leptospires in human tissues. The quantitative results for serum, which showed high levels of leptospiremia in patients who died, mirror those from Truccolo et al. [22] , who found, using a quantitative microplate PCR assay, that the presence of at least 10 4 leptospires/mL of serum was associated with a poor prognosis. As Truccolo et al. [22] propose, multicenter studies are needed to further delineate the association of leptospiremia levels with severity of disease and prognosis, particularly in regions with contrasting patterns of leptospirosis transmission and endemicity.
Acute fever in patients in tropical settings is a diagnostic challenge. This is especially true when complications such as hemoptysis, jaundice, neurological impairment, and renal failure supervene. Other infectious diseases, such as malaria, dengue, yellow fever, viral hepatitis, and tuberculosis, as well as noninfectious disorders, such as small vessel vasculitides, could have conceivably explained the clinical presentations we describe. Without specific investigation for leptospirosis in the context of ongoing surveillance for an ecological and epidemiological study, we would not have made the diagnosis of severe pulmonary leptospirosis, despite its attendant implications for the institution of public health measures and ministerial policy for the diagnosis and control of this disease. Based on the leptospiral strains identified in this and other ongoing studies, control measures aimed against rats (carriers of serovar Icterohaemorrhagiae and strain Var10 [Vinetz, unpublished observation]) and dogs (carriers of serovar Canicola) would have the greatest public health impact.
Interpretation of this study has 2 potential limitations. First, we relied on serologic testing as the primary means of identifying exposure to Leptospira in the patient populations studied. MAT and ELISA simply revealed the presence of high titers of IgM antileptospiral antibodies in the patient populations studied. Some investigators in the leptospirosis field would use the criteria used in this study as evidence of acute leptospirosis [23] [24] [25] . Studies that have used serologic testing to diagnose acute leptospirosis in regions of endemicity have used high cutoff values (i.e., MAT titers of у200 in areas of nonendemicity or у400-800 in areas of endemicity) [23, 26] to enhance the specificity of the test for diagnosis of acute infection. However, MAT titers of у800 are not uncommon in asymptomatic ambulatory individuals in rural villages in the Iquitos region (Vinetz, Segura, Gilman, and Cespedes, data not shown). Therefore, in the present study, we interpret the serologic test results only as an indication of probable recent leptospiral exposure [18] . This study likely underestimates the case-fatality rate of acute leptospirosis and the rate of leptospiral pulmonary hemorrhage because of the very high prevalence of high titers of antileptospiral antibodies in acutely febrile patients from this region of endemicity. Because of the high level of leptospiral exposure in our study populations, it is possible that the number of patients with high titers of antileptospiral antibodies caused an overestimation of the number of febrile patients who actually had acute leptospirosis. Here, we estimate that ∼4% of patients with high titers of antileptospiral antibodies in urban Iquitos had severe pulmonary involvement, with an overall case-fatality rate of 2%. Second, some patients were lost to follow-up, which potentially caused an underestimation of the number of patients who developed severe pulmonary leptospirosis. The study design included active surveillance of hospitalized patients, and outpatient follow-up was successful for 180% of enrolled patients, with the highest rate of loss to follow-up at the Hospital de Apoyo Iquitos. It is possible that some patients lost to follow-up because they were only temporary inhabitants of Iquitos could have had severe pulmonary leptospirosis. If this were true, the number of severe leptospirosis cases would have been underestimated. Further, with our continuous presence in the rural districts and excellent communication with the village health posts, it is likely that we would have learned of severe cases of illness in the area around Iquitos, even with the few patients that were lost to follow-up. But severe cases of illness in the area around Iquitos did not occur. Therefore, the data support our conclusion that severe leptospirosis in the Iquitos region is primarily an urban problem.
Leptospirosis continues to be misidentified because of its variable and often nonspecific clinical presentation. In Iquitos, Peru, leptospirosis appears to be a highly significant cause of morbidity and mortality, far more so than has hitherto been recognized. Because the results of leptospiral serologic tests are still difficult to interpret in regions where leptospiral exposure is common, more effective diagnostic tests need to be developed to focus on rapid demonstration of the etiologic agent in clinical specimens, such as serum or blood. Such testing modalities could be PCR-based, such as those presented here [17] and elsewhere [22, 27] , or they could include antigen detection assays [28] . All inpatients in this study received appropriate antimicrobial therapy at presentation; outpatients did not receive such therapy because they went home before the diagnosis was established or before hemoptysis developed. It remains unclear whether initiation of antimicrobial therapy would have an impact on the prognosis for severe pulmonary leptospirosis, but antimicrobials clearly cannot be withheld from such patients [9] . Improved surveillance is only possible by engaging public health authorities to maintain interest in and support of leptospirosis diagnostic facilities that can provide diagnostic information with a clinically relevant turnaround time, and by educating the public in regions of endemicity to seek early medical attention for fever.
